Novartis | NOVN - PE Price to Earnings

Stock Price
121.18
Daily Change
1.38 1.15%
Monthly
-3.29%
Yearly
46.07%
Q2 Forecast
120.10

Novartis reported 17.85 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Alcon AG 38.19 3.79 Dec/2025
Almirall 79.43 0.3 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
Biogen 14.02 4.63 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Fresenius 15.18 0.63 Dec/2025
Fresenius Medical Care 8.71 1.86 Dec/2025
Galapagos 3.14 50.78 Dec/2025
Genmab 17.14 4.39 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
J&J 23.62 0.86 Dec/2025
Lonza 34.34 2.58 Dec/2025
Merck 20.56 7.18 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 17.85 2.11 Dec/2025
Novartis 17.79 1.74 Dec/2025
Novo Nordisk 12.78 0.01 Dec/2025
Orion 28.54 2.43 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Philips 15.65 4.36 Dec/2025
Recordati 25.3 1.41 Sep/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
UCB 29.7 5.52 Dec/2025